UK Parliament / Open data

Medicines and Medical Devices Safety Review

I can give the hon. Gentleman an absolute assurance that she will do so. In the case of valproate it is very clear what the next steps should be, because there is no dispute over the science. When there is controversy over the science—and I appreciate how distressing that is for the families involved—the first thing we must do is establish the truth of the situation, and that is why we have given Baroness Cumberlege a free hand to look at the whole issue.

Type
Proceeding contribution
Reference
636 c174 
Session
2017-19
Chamber / Committee
House of Commons chamber
Back to top